Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.944 EUR | -4.47% |
|
-13.02% | -20.49% |
Apr. 30 | BIO-UV Group S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Bio-UV: partnership with U.S.-based Pinnacle Ozone | CF |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.53 for the 2024 fiscal year.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Electrical Components & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.49% | 21.11M | - | ||
-1.07% | 141B | A | ||
+22.73% | 134B | B+ | ||
+35.09% | 130B | B+ | ||
+10.32% | 61.42B | A- | ||
+2.20% | 39.01B | B | ||
+86.45% | 33.52B | C | ||
+5.04% | 29.99B | B | ||
-16.74% | 29.47B | B | ||
+12.28% | 28.23B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALTUV Stock
- Ratings BIO-UV Group